Home › Forums › Main Forum › Media & News › HCV New Drugs Blogspot
- This topic has 175 replies, 27 voices, and was last updated 8 years ago by mgalbrai.
-
AuthorPosts
-
11 April 2016 at 7:31 pm #15223
Promising new blood test is first of its kind to detect liver scarring:
http://hepatitiscnewdrugs.blogspot.com/2016/04/promising-new-blood-test-is-first-of.htmlUnderstanding the Magnitude of the Viral Hepatitis Epidemics in the United States
http://hepatitiscnewdrugs.blogspot.com/2016/04/understanding-magnitude-of-viral.htmlHepatitis C Deaths Up Sharply Over Past Decade
http://hepatitiscnewdrugs.blogspot.com/2016/04/hepatitis-c-deaths-up-sharply-over-past.htmlEditorial: ‘Fixing’ drug prices
http://hepatitiscnewdrugs.blogspot.com/2016/04/editorial-fixing-drug-prices.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2425 April 2016 at 6:23 pm #16164Good News!!
Successful antiviral treatment for hepatitis C associated with reduction in risk of cirrhosis, HCC and overall mortality, regardless of age.
http://hepatitiscnewdrugs.blogspot.com/2016/04/successful-antiviral-treatment-for.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2426 April 2016 at 6:28 pm #16213Study show fibrosis is reversible:
http://hepatitiscnewdrugs.blogspot.com/2016/04/pediatric-research-researchers-now.htmlDiabetes and liver disease:
http://hepatitiscnewdrugs.blogspot.com/2016/04/diabetes-ups-risk-of-hospitalization.htmlNew York to require coverage of HCV drugs:
http://hepatitiscnewdrugs.blogspot.com/2016/04/new-york-insurers-to-change-coverage-of.htmlAbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) without Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
http://hepatitiscnewdrugs.blogspot.com/2016/04/abbvie-receives-nda-for-viekira-pak-for.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2427 April 2016 at 11:14 am #16257The reversing fibrosis article almost reads like the affects of DAA’s may be generalised across all the body’s bits ….
“Recent clinical trials have shown that curing hepatitis C with antiviral medications often results in a dramatic resolution of the dense fibrosis that accompanies cirrhosis — far more than previously thought. This shows that fibrosis can be reversed.
In the laboratory, research has created a much better understanding of the biological intricacies of fibrosis.
Going back to the home analogy: We now know that healthy tissues constantly renovate their walls and other support structures. A specific type of cell called a myofibroblast appears to be at the center of this activity.
Realistic strategies for deactivating myofibroblasts have opened up the theoretical possibility that medications or other therapies might halt and even reverse fibrosis — at least in the test tube. Other biochemical pathways that regulate the process of remodeling also seem to be open to therapeutic alteration in the laboratory.”
I didn’t get a sense of how this all worked, but it sounds possible DAA’s may have other unintended uses…? Does it breakdown the fibrosis or just give the liver a fair go at doing this?
I read somewhere about good old interferon possible being effective in reversing Peyronie’s disease in as much as it broke down scar tissue??
It is something with treatment I was hanging my hat on; and it’s good to see an article holding out some hope that getting rid of the bug may help with scaring as well.
Yours
Jeff
3 May 2016 at 7:05 pm #16596A novel approach to solving drug price gouging:
http://hepatitiscnewdrugs.blogspot.com/2016/05/a-legal-approach-to-reducing-drug.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 243 May 2016 at 10:17 pm #16598This article isnt from the Blogspot but a good article nonetheless.
http://www.snopes.com/hepatitis-c-drug-prices/
SVR 24
3 May 2016 at 10:19 pm #16599Interesting! Seems like a kind of “compulsory licence” for the USA? But I could not access the original article. For anyone who wants to follow up further, here is a link:
http://content.healthaffairs.org/content/35/5/791
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).5 May 2016 at 6:23 pm #16730Antiviral therapies give hepatitis C cirrhosis patients similar life expectancy as general population
http://hepatitiscnewdrugs.blogspot.com/2016/05/antiviral-therapies-give-hepatitis-c.htmlHepatitis C Deaths in U.S. Rose in 2014, but New Drugs Hold Promise
http://hepatitiscnewdrugs.blogspot.com/2016/05/hepatitis-c-deaths-in-us-rose-in-2014.htmlIt’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments
http://hepatitiscnewdrugs.blogspot.com/2016/05/its-time-to-end-insurance-restrictions.htmlHepatitis C virus and neurological damage
http://hepatitiscnewdrugs.blogspot.com/2016/05/hepatitis-c-virus-and-neurological.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2410 May 2016 at 6:50 pm #16925Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection
http://hepatitiscnewdrugs.blogspot.com/2016/05/metabolic-manifestations-and.html
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 2410 May 2016 at 9:02 pm #16927I don’t know if this has already posted here or somewhere else in the forum (sorry if it has)
I just received in an email this am.
http://www.upi.com/Health_News/2016/04/17/Study-Generic-hepatitis-C-drugs-as-effective-as-brand-names/1601460939760/
Note the comments at end of article
GT1a; Got it some time in the 70’s; Diagnosed @1976
Tx naive
METAVIR: A2-F2
SOT May 18, 2016: CMP: AST 162 ALT 241 VL 13000000
3 weeks after SOT: AST 27 ALT 31 VL 138
Reached EOT Aug. 10, 2016 / Received svr4 results Sept. 20, 2016: AST 22 ALT 24
Hep C RNA NOT DETECTED”11 May 2016 at 4:38 am #16939“I didn’t get a sense of how this all worked, but it sounds possible DAA’s may have other unintended uses…? Does it breakdown the fibrosis or just give the liver a fair go at doing this?”
DAAs must inactivate CB1 because receptor CB1 is crucial for fibroblast activation. Inactivation of CB1 exerts potent antifibrotic effect. On the other hand Hepatitis C Virus up-regulates the Cannabinoid Receptor 1
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0012841
“I read somewhere about good old interferon possible being effective in reversing Peyronie’s disease in as much as it broke down scar tissue?”
I’ve seen one case of Peyrone’s caused by interferon.
P.
11 May 2016 at 5:33 am #16948So if someone has had HCV and now has very advanced fibrosis and has had a liver cancer that will come back and they don’t have enough unaffected liver to regenerate, could these DAAs help repair their fibrosis?
Genotype 1a
Diagnosed in 2004, had HCV for all my adult life. Until 2016!!!!
Harvoni treatment, started 19 March 2016
4 week results Bilirubin 12 down from 14 pre treatment,
Gamma 25 down from 52, ALT 19 down from 63, AST 19 down from 47,
VL <15 down from a lazy 6 million or soEOT Results
Bilirubin 10, GGT 18, ALT 19, AST 21, VL UND12 Weeks post EOT
Bilirubin 11, GGT 16, ALT 22, AST 20, VL UND
Cured baby11 May 2016 at 6:13 am #16953DAAs must inactivate CB1 because receptor CB1 is crucial for fibroblast activation.
No, there is no evidence of inactivation of CB1 by DAAs. There is evidence that DAAs destroy the Hepatitis C Virus and that the absence of HCV reduces up-regulation of CB1.
Inactivation of CB1 exerts potent antifibrotic effect.
No, but there is evidence that “CB1 inactivation has been shown to inhibit the progression of fibrosis” which differs from your claim of a potent antifibrotic effect.
On the other hand Hepatitis C Virus up-regulates the Cannabinoid Receptor 1
Agree. See point 1 above.
I’ve seen one case of Peyrone’s caused by interferon.
Err, no. I suspect you have seen one case of Peyronie’s disease coincident with interferon use and have jumped from effect to cause. Available scientific evidence is currently contradictory regarding any link to something that effects up to 5% of the male population anyway.
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
11 May 2016 at 6:45 am #16954Hi beaches,
My reading of the available evidence is that the DAAs remove the HCV and the absence of HCV reduces inflammation. Inflammation is what causes fibrosis and eventually HCC. So if inflammation is reduced and fibrosis is not being created then the liver has a better chance of regenerating and there is less risk of HCC forming. If you have enough healthy liver to currently support you then there is an opportunity for it to regenerate. The problem is when your liver can’t support you from day to day, at that point you need a transplant anyway, although no longer having HCV thanks to the DAAs means your new liver won’t get infected.
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
11 May 2016 at 6:51 am #16955Thanks Gaj
I was asking on behalf of a very dear friend. Made it through Peginf +riba….. just (long story).
She has since had a bout of HCC. Was able to have it removed, but it does come back and she doesn’t have enough healthy liver to regenerate and can’t have any more cut out. Not unique I’m sure but it still sucks.
Genotype 1a
Diagnosed in 2004, had HCV for all my adult life. Until 2016!!!!
Harvoni treatment, started 19 March 2016
4 week results Bilirubin 12 down from 14 pre treatment,
Gamma 25 down from 52, ALT 19 down from 63, AST 19 down from 47,
VL <15 down from a lazy 6 million or soEOT Results
Bilirubin 10, GGT 18, ALT 19, AST 21, VL UND12 Weeks post EOT
Bilirubin 11, GGT 16, ALT 22, AST 20, VL UND
Cured baby -
AuthorPosts
- You must be logged in to reply to this topic.